Indeed, consistently to our findings, increased adiponectin levels consequently to PTP1B inhibition has been correlated to an amelioration of insulin sensitivity and a resulting decreased hyperinsulinemia and glucose intolerance in various animal models (96–99). Here, ADIPOQ is linked to hyperinsulinism.